Theratechnologies gives results of late stage HIV study
Theratechnologies gives results of late stage HIV study
- Theratechnologies announces results from the last pivotal phase iii trial of hiv long acting biologic (lab) investigational antiretroviral ibalizumab.
- Theratechnologies announces results from the last pivotal phase iii trial of hiv long acting biologic (lab) investigational antiretroviral ibalizumab.